July 22, 2024

BD to reinforce the region’s healthcare stance with cutting-edge technology and solutions at Arab Health and Medlab 2022

 BD to reinforce the region’s healthcare stance with cutting-edge technology and solutions at Arab Health and Medlab 2022

Company to showcase a comprehensive suite of proven and trusted MedTech solutions enhancing the patient treatment experience.

Dubai, United Arab Emirates 19, January 2022 – The Dubai branch of BD (Becton, Dickinson, and Company) (NYSE: BDX), a leading global medical technology company, is all set to present its latest innovations and solutions focused on Patient Safety to support clinicians’ efforts to move from piecemeal interventions to a total systems approach for safety at Arab Health and Medlab Middle East 2022, two of the region’s leading medical technology events taking place from January 24-27, 2022, at the Dubai World Trade Centre.

“The pandemic put the healthcare sector to the test in terms of stability and preparedness, demonstrating the need for healthcare providers to adopt advanced technology to meet the growing needs of patients,” said Maher Elhassan, Vice President and General Manager, BD Middle East, North Africa, and Turkey. “Avenues like Arab Health and Medlab give us an invaluable opportunity to raise awareness while facilitating the necessary impetus to our movement of securing and improving the patient care journey for both medical professionals and patients alike. Now more than ever, is the time for organisations and medical institutions to collaborate and achieve greater milestones in patient safety and BD will do everything in its capacity to provide best-in-class MedTech products and services, as we pursue our purpose of advancing the world of health”.

At Arab Health 2022, the company will demonstrate the full potential of its innovations through the collaboration of its Medical segment with Medication Management Systems and Medication Delivery Systems, and the BD Interventional segment. BD will display a series of solutions that will focus on the prevention of potential medication errors and Healthcare-Associated Infections (HAIs) alongside innovations that will empower medical professionals to perform timely, accurate and appropriate diagnostics practices to support effective decision making in providing the safest and most effective care possible in the region.

Additionally, at Medlab 2022, the company’s Lifesciences segment will showcase integrated diagnostic solutions and services, including safe and integrated specimen collection, specimen diagnosis and data management for better patient comfort. The company will also present solutions that incorporate artificial intelligence to drive laboratory efficiency with customised microbiology automation platforms and dedicated value-added services.

Furthermore, experts from BD will be hosting insightful sessions at the company’s booth, highlighting the best practices, and demonstrating a range of products and services to address the region’s latest healthcare challenges, providing a safer and efficient healthcare system.